Hemant Surgical Industries Ltd
Hemant Surgical Industries Ltd (HSIL) last reported results for the quarter ended Mar 2026, with sales of ₹167 crore and net profit of ₹13 crore. The stock last traded at ₹634, a market capitalisation of ₹921 crore, on a P/E of 54.6. Over the past 52 weeks the stock has ranged between ₹215 and ₹634. Figures are as of 6 Oct 2026 and are not real time.
Hemant Surgical Industries Ltd share price and key metrics
- Current price
- ₹634
- Market cap
- ₹921 cr
- Stock P/E
- 54.6
- Book value
- ₹106
- ROE
- 16.8%
- ROCE
- 19.2%
- Dividend yield
- 0.00%
- 52w high / low
- 634/215
Metrics as of 6 Oct 2026. Not real time.
Track Hemant Surgical Industries Ltd
Cruxal reads every Hemant Surgical Industries Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Hemant Surgical Industries Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 117%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 113%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 45%
- 1 Year
- 103%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- 17%
Hemant Surgical Industries Ltd quarterly results
| ₹ crore | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 58 | 65 | 167 |
| Expenses | 52 | 57 | 152 |
| Operating profit | 5 | 8 | 16 |
| OPM % | 9% | 12% | 9% |
| Other income | 3 | 2 | 4 |
| Interest | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 |
| Profit before tax | 6 | 7 | 16 |
| Tax % | 19% | 25% | 22% |
| Net profit | 5 | 5 | 13 |
| EPS (₹) | 4.66 | 4.19 | 9.76 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Hemant Surgical Industries Ltd annual results
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 107 | 232 |
| Operating profit | 9 | 24 |
| OPM % | 9% | 10% |
| Net profit | 8 | 18 |
| EPS (₹) | 7.70 | 13.95 |
TTM is the trailing twelve months to the most recent quarter.
Hemant Surgical Industries Ltd balance sheet
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 10 | 13 |
| Reserves | 53 | 125 |
| Borrowings | 31 | 50 |
| Other liabilities | 54 | 87 |
| Total liabilities | 148 | 274 |
| Fixed assets | 40 | 53 |
| CWIP | 12 | 0 |
| Investments | 1 | 0 |
| Other assets | 95 | 221 |
| Total assets | 148 | 274 |
As reported by the company. Total assets equal total liabilities by construction.
Hemant Surgical Industries Ltd cash flow
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operations | 5 | -32 |
| Cash from investing | -30 | -3 |
| Cash from financing | 22 | 69 |
| Net cash flow | -4 | 34 |
| Free cash flow | -30 | -37 |
| CFO / operating profit | 72% | -117% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Hemant Surgical Industries Ltd operating ratios
| Per year | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | — | 19% |
| Debtor days | 70 | 106 |
| Inventory days | 208 | 121 |
| Days payable | 188 | 146 |
| Cash conversion cycle | 90 | 81 |
| Working capital days | 62 | 24 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Hemant Surgical Industries Ltd shareholding pattern
Promoters held 52.83% at May 2026, down from 73.56% at Sep 2024. FIIs 0.14% and DIIs 19.94%.
| % held | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | May 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 73.56% | 73.56% | 73.56% | 73.56% | 58.90% | 58.90% | 52.83% |
| FIIs | 0.03% | 0.00% | 0.00% | 0.39% | 0.15% | 0.15% | 0.14% |
| DIIs | 4.26% | 1.97% | 1.13% | 1.11% | 10.81% | 10.73% | 19.94% |
| Public | 22.14% | 24.47% | 25.31% | 24.93% | 30.13% | 30.21% | 27.10% |
| No. of shareholders | 722 | 1,229 | 1,248 | 1,229 | 758 | 841 | 948 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Hemant Surgical Industries Ltd corporate filings
- Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026Company Updatelow impact
- Hemant Surgical Industries Limited passes all three resolutions at AGM with 100% approval, including adoption of financial statements, re-appointment of director, and ratification of cost auditor remunerationAGM/EGMlow impact
Cruxal's analysis: Hemant Surgical Industries Limited conducted its 37th AGM on September 29, 2026, with all…
Read the full analysis - Hemant Surgical Industries Limited holds AGM on September 29, 2026; no new financial disclosures or strategic events announcedAGM/EGMlow impact
Cruxal's analysis: Hemant Surgical Industries Limited conducted its 37th AGM on September 29, 2026, via…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Hemant Surgical Industries Ltd announces 37th Annual General Meeting and remote e-voting scheduleCompany Updatelow impact
Cruxal's analysis: Hemant Surgical Industries Ltd has published a newspaper notice regarding the convening…
Read the full analysis - Hemant Surgical Industries Limited Announces 37th Annual General Meeting (AGM) for September 29, 2026Company Updatelow impact
Cruxal's analysis: Hemant Surgical Industries Limited has issued a notice for its 37th Annual General…
Read the full analysis - Hemant Surgical Industries Ltd. schedules 37th Annual General Meeting for September 29, 2026Otherslow impact
Cruxal's analysis: Hemant Surgical Industries Ltd. has announced the approval of its Directors' Report and…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.